IL6 and Sepsis: Likewise, administration of the MGMT inhibitor in LPS-activated wild-type (WT) macrophages also demonstrated anti-inflammatory effects through these parameters (except for supernatant IL-6) (Figure 3I–P), suggesting a possible use of MGMT inhibitor to attenuate sepsis-induced hyperinflammation.